A new trading day began on Friday, with Relay Therapeutics Inc (NASDAQ: RLAY) stock price up 2.37% from the previous day of trading, before settling in for the closing price of $4.64. RLAY’s price has ranged from $4.48 to $12.14 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 319.82%. Meanwhile, its annual earnings per share averaged 8.22%. With a float of $121.92 million, this company’s outstanding shares have now reached $127.46 million.
Let’s determine the extent of company efficiency that accounts for 323 employees. In terms of profitability, gross margin is 58.64%, operating margin of -3926.55%, and the pretax margin is -3449.92%.
Relay Therapeutics Inc (RLAY) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Relay Therapeutics Inc is 27.16%, while institutional ownership is 73.12%. The most recent insider transaction that took place on Oct 28 ’24, was worth 9,823. In this transaction an insider of this company sold 1,621 shares at a rate of $6.06, taking the stock ownership to the 390,063 shares. Before that another transaction happened on Oct 28 ’24, when Company’s Chief Financial Officer sold 6,802 for $6.06, making the entire transaction worth $41,220. This insider now owns 306,391 shares in total.
Relay Therapeutics Inc (RLAY) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.67 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.61 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.22% per share during the next fiscal year.
Relay Therapeutics Inc (NASDAQ: RLAY) Trading Performance Indicators
Here are Relay Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 18.42. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 81.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.61, a number that is poised to hit -0.61 in the next quarter and is forecasted to reach -2.64 in one year’s time.
Technical Analysis of Relay Therapeutics Inc (RLAY)
Looking closely at Relay Therapeutics Inc (NASDAQ: RLAY), its last 5-days average volume was 2.07 million, which is a jump from its year-to-date volume of 1.46 million. As of the previous 9 days, the stock’s Stochastic %D was 10.91%. Additionally, its Average True Range was 0.35.
During the past 100 days, Relay Therapeutics Inc’s (RLAY) raw stochastic average was set at 4.33%, which indicates a significant decrease from 13.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.85% in the past 14 days, which was lower than the 94.07% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.36, while its 200-day Moving Average is $7.31. However, in the short run, Relay Therapeutics Inc’s stock first resistance to watch stands at $4.89. Second resistance stands at $5.04. The third major resistance level sits at $5.17. If the price goes on to break the first support level at $4.61, it is likely to go to the next support level at $4.48. Should the price break the second support level, the third support level stands at $4.33.
Relay Therapeutics Inc (NASDAQ: RLAY) Key Stats
With a market capitalization of 813.92 million, the company has a total of 167,383K Shares Outstanding. Currently, annual sales are 25,550 K while annual income is -341,970 K. The company’s previous quarter sales were 0 K while its latest quarter income was -92,210 K.
